International Collaborative Study of Newly Diagnosed Extranodal NK/T-Cell Lymphoma Patients diagnosed between 2014 and 2021 -International ENKL project 2025-

International ENKL project 2025 - ENKL2025

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056213

Enrollment

568

Registered

2024-11-20

Start date

2025-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

newly diagnosed extranodal NK/T-cell lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All cases of ENKL diagnosed from January 1, 2014, to December 31, 2021, at participating institutes in this study will be included.

Exclusion criteria

Exclusion criteria: 1. Case which diagnosis is not matched with the diagnostic criteria of extranodal NK/T-cell lymphoma suggested in WHO classification. 2. Case which is withdrawn to register this study.

Design outcomes

Primary

Measure	Time frame
1. To understand the demographics in each country 2. To assess the trend of prognosis and treatment 3. To evaluate prognostic factors and treatment response 4. Finally, to elucidate the best management of ENKL patients	—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe

Contacts

Public ContactAyumi Fujimoto

Department of Internal Medicine, Faculty of Medicine, Shimane University Division of Hematology and Oncology

afujimot@med.shimane-u.ac.jp0853-20-2308

Outcome results